Get the Stockscreener App
8.84
2.43%
0.21
Alpha Cognition Inc stock is traded at $8.84, with a volume of 247.59K.
It is up +2.43% in the last 24 hours and up +9.81% over the past month.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
See More
Previous Close:
$8.63
Open:
$9.34
24h Volume:
247.59K
Relative Volume:
3.60
Market Cap:
$192.48M
Revenue:
$10.83M
Net Income/Loss:
$-25.14M
P/E Ratio:
-6.4413
EPS:
-1.3724
Net Cash Flow:
$-30.41M
1W Performance:
-3.18%
1M Performance:
+9.81%
6M Performance:
+81.15%
1Y Performance:
+10.50%
1-Day Range:
$8.20
$9.50
1-Week Range:
$8.20
$9.50
52-Week Range:
$4.50
$9.9999
Alpha Cognition Inc Stock (ACOG) Company Profile
Name
Alpha Cognition Inc
Sector
Industry
Phone
(858) 344-4375
Address
1452 HUGHES RD., STE. 200, GRAPEVINE
Compare ACOG vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
8.84 | 194.88M | 10.83M | -25.14M | -30.41M | -1.3724 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Initiated | Craig Hallum | Buy |
| Mar-18-25 | Initiated | H.C. Wainwright | Buy |
Alpha Cognition Inc Stock (ACOG) Latest News
Alpha Cognition (NASDAQ:ACOG) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Why is Alpha Cognition stock surging today? By Investing.com - Investing.com Canada
Alpha Cognition Q2 Revenue Surges 270% to $6.09 Million - Minichart
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update - BioSpace
Alpha Cognition (ACOG) Q2 2026 Earnings Call Transcript - AOL.com
Alpha Cognition (NASDAQ:ACOG) Announces Quarterly Earnings Results - MarketBeat
Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates - sharewise.com
ACOG: ZUNVEYL achieved 71% sequential revenue growth in Q2 2026, driven by strong long-term care adoption - TradingView
Alpha Cognition Q2 Earnings Call Highlights - MarketBeat
Alpha Cognition Q2 Results: Revenue Up 71% QoQ To $6 Million - scanx.trade
Earnings call transcript: Alpha Cognition posts strong Q2 2026 sales growth - Investing.com
Alpha Cognition Q2 2026 Earnings Call Transcript - benzinga.com
Alpha Cognition (ACOG) doubles H1 2026 revenue as cash burn accelerates - Stock Titan
Alpha Cognition Inc. Q2 2026: Revenue $6.09M, EPS $(0.40) — 10-Q Summary - TradingView
Alpha Cognition reports Q2 revenue growth, narrows loss By Investing.com - Investing.com Nigeria
ALPHA COGNITION ($ACOG) Releases Q2 2026 Earnings, Stock Rises - quiverquant.com
Earnings Preview: ACOG to Report Financial Results Post-market on August 13 - Moomoo
Alpha Cognition Inc (ACOG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance
Alpha Cognition (ACOG) to Announce Quarterly Earnings on Thursday - MarketBeat
Major Investor Ramps Up Position in Alpha Cognition Inc., Signaling Renewed Confidence - TipRanks
Alpha Cognition Inc. (ACOG) shares bought by Opaleye Management - Stock Titan
Press Release: Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update - 富途牛牛
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update - Business Wire
Alpha Cognition Inc. (NASDAQ:ACOG) Short Interest Up 66.0% in July - MarketBeat
Opaleye Management Inc. Boosts Stake in Alpha Cognition Inc (ACO - GuruFocus
Alpha Cognition receives European patent for Alzheimer’s drug By Investing.com - Investing.com Nigeria
Alpha Cognition Inc. (ACOG) Surges 8.6%: Is This an Indication of Further Gains? - Yahoo Finance
Alpha Cognition Inc. (ACOG) holder Opaleye buys 130 shares - Stock Titan
Alpha Cognition Inc (ACOG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alpha Cognition Inc (ACOG) Balance Sheet - TradingKey
Alpha Cognition Inc (ACOG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Alpha Cognition Inc (ACOG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alpha Cognition Inc (ACOG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ACOG|Alpha Cognition Inc|Price:8.570|Chg%:+0.670 - TradingKey
Alpha Cognition Inc (ACOG) Income Statement - TradingKey
ACOG|Alpha Cognition Inc|Price:7.900|Chg%:-0.330 - TradingKey
Alpha Cognition Inc. Revenue Breakdown – BOATS:ACOG - TradingView
Major Investor Doubles Down on Alpha Cognition With Bold New Stake - TipRanks
Alpha Cognition Inc. (ACOG) sees 200,086-share buy by 10% holder - Stock Titan
Playing The Biotech Breakout With Insiders - Seeking Alpha
ACOG Options Volatility — NASDAQ:ACOG - TradingView
ACOG Options Chain — NASDAQ:ACOG - TradingView
Alpha Cognition Inc. (ACOG) reports Q1 loss, tops revenue estimates - MSN
Alpha Cognition’s RESOLVE Study: Fresh Real‑World Data on Zunveyl in Alzheimer’s Care - TipRanks
Alpha Cognition (ACOG) Proxy Filing Summary - Quartr
Alpha Cognition Inc. (ACOG) Edges Higher as Stock Tests Key Resistance LevelsOBV Breakout - dars.gov.et
Raymond James Starts Alpha Cognition (ACOG) at Outperform - Yahoo Finance
Alpha Cognition (ACOG) Stock Fair Value Moves Lower As Analysts Weigh Zunveyl Persistence - Yahoo Finance
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit - Lelezard
ACOG Initiates Coverage by Raymond James -- Rating Set to Outper - GuruFocus
Alpha Cognition Inc Stock (ACOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):